financetom
Business
financetom
/
Business
/
Warner Bros Discovery to separate studios and streaming in two-way split
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Warner Bros Discovery to separate studios and streaming in two-way split
Jun 9, 2025 4:38 AM

(Reuters) -Warner Bros Discovery said on Monday it would split into two companies, separating its studios and streaming business from its fading cable television networks as the parent of HBO and CNN looks to compete better in the streaming era.

Its CEO David Zaslav will lead the streaming and studios business after the breakup, while CFO Gunnar Wiedenfels will head the Global Networks unit that includes the cable assets.

"By operating as two distinct and optimized companies in the future, we are empowering these iconic brands with the sharper focus and strategic flexibility they need to compete most effectively in today's evolving media landscape," Zaslav said.

The media industry is going through what some executives have called a "general disruption" as millions of subscribers abandon the once-lucrative cable TV for streaming.

That has piled pressure on companies to consistently produce hit studio content and boost profitability in their streaming businesses.

WBD had laid the groundwork for a possible sale or spin-off of its declining cable TV assets in December by announcing a separation from its streaming and studio operations.

The split will align the company with Comcast, which is spinning off most of its cable TV networks such as MSNBC and CNBC.

(Reporting by Aditya Soni and Akash Sriram in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday it received approval from the European Commission for Adzynma for the treatment of congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder caused by a deficiency in the ADAMTS13 enzyme. Takeda said the EC approval does not have any impact on its consolidated forecast for the...
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Aug 7, 2024
11:49 AM EDT, 08/07/2024 (MT Newswires) -- ShaMaran Petroleum ( SHASF ) on Wednesday said it closed the acquisition of TAQA Atrush and the subsequent sale of an indirect interest in Atrush to HKN Energy IV. The two-step transaction announced in January increased ShaMaran's 28% indirect stake in the Atrush oil block in Iraq's Kurdistan region to a 50% working...
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Aug 7, 2024
On Tuesday, Emergent BioSolutions Inc. ( EBS ) reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the consensus of $190 million. The company reported an adjusted EPS loss of $(2.32), more than double the $(1.05) reported a year ago, missing the consensus of $(0.94). Revenues from Narcan (naloxone HCl) Nasal Spray decreased 10% to $120 million, primarily...
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- KITS Eyecare ( KTYCF ) on Wednesday said it swung to a profit in the second-quarter as revenue jumped 26% to a record. The on-line eyeglasses company said its second-quarter came in at $187,000, or $0.01 per share, swinging from a loss of $1.2 million, or $0.04, in the year-prior period. Revenue rose...
Copyright 2023-2026 - www.financetom.com All Rights Reserved